Status:
COMPLETED
Risk Factors of Stroke or Systemic Embolism After Atrial Fibrillation Ablation
Lead Sponsor:
Korea University Guro Hospital
Collaborating Sponsors:
Hanmi Pharmaceutical Company Limited
Conditions:
Atrial Fibrillation
Eligibility:
All Genders
Brief Summary
To investigate the rate and risk factors of stroke or systemic embolism (SE) following atrial fibrillation (AF) ablation.
Detailed Description
Since catheter ablation for AF reduces the burden of AF effectively, several studies have demonstrated that catheter ablation not only improves the quality of life but also reduces the risk of stroke ...
Eligibility Criteria
Inclusion
- Patients who underwent catheter ablation for AF
Exclusion
- None
Key Trial Info
Start Date :
May 17 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 14 2018
Estimated Enrollment :
3198 Patients enrolled
Trial Details
Trial ID
NCT03479073
Start Date
May 17 2017
End Date
June 14 2018
Last Update
June 18 2018
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Korea University Anam Hospital
Seoul, South Korea
2
Korea University Guro Hospital
Seoul, South Korea
3
Seoul National University Hospital
Seoul, South Korea